Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Depreciation and Depletion: 2019-2024

Historic Depreciation and Depletion for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Dec 2024 value amounting to $640,000.

  • Arcutis Biotherapeutics' Depreciation and Depletion fell 10.00% to $153,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $623,000, marking a year-over-year decrease of 21.64%. This contributed to the annual value of $640,000 for FY2024, which is 20.00% down from last year.
  • As of FY2024, Arcutis Biotherapeutics' Depreciation and Depletion stood at $640,000, which was down 20.00% from $800,000 recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Depreciation and Depletion peaked at $800,000 during FY2023, and registered a low of $122,000 during FY2020.
  • Its 3-year average for Depreciation and Depletion is $687,333, with a median of $640,000 in 2024.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Depreciation and Depletion skyrocketed by 309.84% in 2021 and then fell by 20.00% in 2024.
  • Yearly analysis of 5 years shows Arcutis Biotherapeutics' Depreciation and Depletion stood at $122,000 in 2020, then skyrocketed by 309.84% to $500,000 in 2021, then climbed by 24.40% to $622,000 in 2022, then increased by 28.62% to $800,000 in 2023, then fell by 20.00% to $640,000 in 2024.